Clinical Trials Logo

Renal Function Disorder clinical trials

View clinical trials related to Renal Function Disorder.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04070885 Completed - Clinical trials for Renal Function Disorder

Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.

NéphroTest
Start date: January 5, 2011
Phase:
Study type: Observational

This study aims to conduct a prospective collection of clinical and para-clinical data in patients with Chronic Renal Diseases to identify disease progression factors, markers of renal function, and the pathophysiology of Chronic Renal Diseases complications.

NCT ID: NCT04069871 Completed - Critical Illness Clinical Trials

Transcutaneous Electrical Nerve Stimulation for Tissues Perfusion

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of transcutaneous electrical nerve stimulation in mechanically ventilated patients on the lower limb and renal tissue perfusion.

NCT ID: NCT02549066 Completed - Clinical trials for Renal Function Disorder

Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation

ICAROX
Start date: January 2016
Phase: N/A
Study type: Interventional

Cardiac surgery with cardiopulmonary bypass (CPB), especially when oxygen delivery is low, is associated with acute kidney injury. Unpublished data shows that renal oxygen delivery is compromised during CPB due to low hematocrit and redistribution of blood flow away from the kidneys. We wish to study if increased CPB flow can improve renal oxygenation. Patients who develop cardiac failure after weaning from CPB will be treated as per our departments routine with the inotropic agent milrinone, and measurements will be made before and after treatment.

NCT ID: NCT02522104 Completed - Sickle Cell Disease Clinical Trials

Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)

Start date: September 3, 2015
Phase: Phase 4
Study type: Interventional

The use of hydroxyurea in sickle cell disease patients with glomerular hyperfiltration and renal failure requires a specific monitoring and dose adjustment in order to remain within the therapeutic interval while limiting the risk of toxicity or therapeutic failure. For this reason the investigators propose to compare the pharmacokinetic parameters of hydroxyurea in normal-renal function sickle cell patients to those of patients with glomerular hyperfiltration or moderate renal failure.

NCT ID: NCT02443363 Completed - Clinical trials for Renal Function Disorder

Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula MDRD, CKD-EPI or Cockroft-Gault?

eGFR
Start date: April 2015
Phase: N/A
Study type: Observational

The study included 300 patients who are post-kidney transplantation (> 3 months and <10 years). An analysis of body composition using bioelectrical impedance, calculated BMI and serum creatinine was determined. Glomerular filtration rate (GFR) was calculated using the formula CKD-EPI, Modification of Diet in Renal Disease (MDRD) and Cockroft-Gault.

NCT ID: NCT02013596 Completed - Clinical trials for Renal Function Disorder

Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum

TRIP
Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effect of TEAS pretreatment and treatment on hepatic and renal dysfunction induced by pneumoperitoneum in patients undergoing laparoscopic surgeries.

NCT ID: NCT01948336 Completed - Clinical trials for Hemodynamic Instability

The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients

Start date: April 2012
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate the effect of dexmedetomidine infusion on early stage renal function.

NCT ID: NCT01255020 Completed - Clinical trials for Renal Function Disorder

Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients

Start date: March 2010
Phase: N/A
Study type: Interventional

The prospective, double blind randomized, parallel control, and multi-center clinical trial will evaluate the safety and efficacy of α-keto acid with restricted protein diet on protecting residual renal function in continuous ambulatory peritoneal dialysis (CAPD) patients.

NCT ID: NCT01092260 Completed - Clinical trials for Renal Function Disorder

Renal Function Measurements in Children

Start date: April 2010
Phase: N/A
Study type: Observational

The purpose of this study is to validate a feasible, safe and reliable iohexol plasma clearance method in routine monitoring of the renal function (GFR) in children. Different parameters of renal function will be compared to the gold standard multiple sample points procedure of iohexol clearance.

NCT ID: NCT00721773 Completed - Clinical trials for Renal Function Disorder

Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

Start date: September 2008
Phase: N/A
Study type: Interventional

This is a multicentre study examining the effectiveness of angiotension converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) or a combination of both in reducing the rate of decline in residual renal function (RRF) in continuous ambulatory peritoneal dialysis (CAPD) patients.